May 19, 2022Anavex Life Sciences to Present at the H. C. Wainwright Global Investment Conference 2022
May 3, 2022Anavex Life Sciences to Announce Fiscal 2022 Second Quarter Financial Results on Tues. May 10, 2022
Apr 27, 2022Anavex Life Sciences Announces Presentations at the IRSF Rett Syndrome Scientific Meeting
Mar 15, 2022Anavex Life Sciences Announces Presentation of Phase 2 Clinical Biomarker Data from PDD study
Feb 10, 2022Anavex Life Sciences to Present at the 11th Annual SVB Leerink Global Healthcare Conference
Sep 26, 2021Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access
Sep 8, 2021Anavex Life Sciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 12, 2021Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Third Quarter Financial Result
Aug 4, 2021Anavex Life Sciences to Announce Fiscal 2021 3rd Quarter Financial Results on Thurs., Aug. 12, 2021
May 13, 2021Anavex Life Sciences Reports Fiscal 2021 Second Quarter Financial Results And Business Outlook
May 6, 2021Anavex Life Sciences Announces Participation at Precision in Clinical Trials Virtual Summit
May 5, 2021Anavex Life Sciences to Announce Fiscal 2021 2nd Quarter Financial Results and Business Outlook
Apr 25, 2021Anavex Life Sciences to Present at the B. Riley Securities’ Virtual Neuroscience Conference
